Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized medicine, announced today that the My5-FU™ Assay will be part of the Saladax Biomedical Laboratories MyCare™ service offering when the CLIA laboratory located at Ben Franklin TechVentures, Bethlehem commences operations later this year. My5-FU is a simple blood test that provides oncologists with objective information to guide optimized dosing for chemotherapy, controlling toxic side effects and improving treatment efficacy for cancer patients. Read more.
Client & Alumni News
Ben Franklin Client Saladax to Offer all MyCare™ Therapeutic Dose Management Assays in the U.S.
The Ben Franklin Technology Partners is an initiative of the Pennsylvania Department of Community and Economic Development and is funded by the Ben Franklin Technology Development Authority.